Vaccine service provider database


A number of new vaccines are being developed against diseases of poverty of major public health importance at global level. The development of these vaccines is facing the same kind of challenges and gaps, which still prevent the following: a) establishment of readily accessible formulation and scale-up process development capacity for neglected disease vaccines; b) establishment of a systematic approach for prioritising formulation of vaccine candidates using accepted preclinical criteria; c) development of information-sharing tools to strengthen connections between scientists, developers and clinical investigators.

The European vaccine community needs to establish both a shared vision and goals to identify the activities required to address these challenges. Cooperation between the different groups of PRD vaccine developers will bring innovative approaches for accelerating the development of effective vaccines.

The database aims to help with the following issues:

  • Difficulties in accessing some technology platforms, such as synthetic peptides/recombinant proteins and expertise for good manufacturing practice (GMP) development, therefore allowing rational decisions to be made based on the best industrial approach for pharmaceutical development;
  • Difficulties in accessing certain types of knowledge and know-how, such as lyophilisation and lack of formulation platforms accessible to academic groups;
  • Difficulties in accessing some delivery platforms, such as adjuvants and virus-like particles for GMP development and/or to assess the quality and regulatory compliance of those platforms;
  • Difficulties in harmonising the safety data collection;
  • Insufficient numbers of trained scientists able to undertake leadership roles in vaccine development.


Please insert your credentials and click 'Login'. Click here if you forgot your password.


Overview of news and links.


European Vaccine Initiative

The European Vaccine Initiative (EVI) is leading European efforts to develop effective, accessible... more



Optimisation of the development of poverty-related-diseases (PRD) vaccines by... more


Service providers:17
Total number of users: 55